Skip to content

The effect of intravenous magnesium sulfate in the treatment of patients with chronic obstructive pulmonary disease

The effect of intravenous magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014111519962N1
Enrollment
90
Registered
2015-02-04
Start date
2015-01-30
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary disease with acute exacerbation, unspecified

Interventions

Intervention 1: intervention in control group: receive 5 cc of sterile water in 50 cc normal saline. Intervention 2: intervention in case group: infusion of 2.5 grams of Mgso4 in 50 cc normal saline i

Sponsors

Vice Chanceller for research of Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: patient older than 18 years acute exacerbation of COPD

Exclusion criteria

Exclusion criteria: any other underlying causes for dyspnea including heart failure, asthma, renal failure, pneumothorax, pneumoni Not willingness to participate

Design outcomes

Primary

MeasureTime frame
Subjective improvement of dyspnea. Timepoint: First time after the initial dose of nebulized bronchodilator and second time after the treatment protocol (3 doses of bronchodilators and even Magnesium or placebo infusion). Method of measurement: patient were asked about severity of dyspnea based on the 10 point likert scale.;Peak Expiratory Flow Rate(PEFR) improvement. Timepoint: First time after the initial dose of nebulized bronchodilator and second time after the treatment protocol (3 doses of bronchodilators and even Magnesium or placebo infusion). Method of measurement: Peak-flow-metry.

Secondary

MeasureTime frame
Intubation during the course of admition. Timepoint: any time during first 12 hours of admition. Method of measurement: Based on patients records.;Length of hospital stay. Timepoint: time of discharge from hospital. Method of measurement: Based on patients records.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElnaz Vafadar Moradi

Mashhad University of Medical Sciences - Imam Reza hospital

elnaz.vafadar@gmail.com+98 51 3852 5312

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026